Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01640665
Title Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Yale University

gastrointestinal system cancer

breast cancer


Capecitabine + Sorafenib

Age Groups: adult
Covered Countries USA

No variant requirements are available.